Multiple Sclerosis Flashcards
What is the strongest genetic predictor of MS?
HLA-DRB1*1501 (2x-4x increased risk)
Other risk factors: female, northern latitudes, exposure to EBV
How is MS diagnosed?
Formally diagnosed using the McDonald critera (updated in 2017), requires demonstration of CNS demyelinating lesions disseminated in time and space and exclusion of other diagnoses
What is Uhthoff phenomenon?
Transient worsening of MS symptoms by heat
What is Lhermitte sign?
Passive neck flexion causes shooting, electric pain in neck and shoulders (dural tension - irritating the already irritated myelin)
What are MS-typical CNS regions on imaging?
juxtacortical/cortical, periventricular, infratentorial, spinal cord
Type of MS?
Intermittent acute attacks with return to neurological baseline (or near-neurological baseline) between episodes
Relapsing-remitting MS (85%)
Type of MS?
initial attack which may be compatible w/ MS, in which full diagnostic criteria may not be met
Clinically Isolated Syndrome (CIS)
Type of MS?
Gradual progression of symptoms from onset of disease
Primary progressive MS (PPMS)
Male sex and spinal cord lesions are predictive of PPMS
Type of MS?
Patients start with relapsing-remitting episodes, but later develop a progressive course?
Secondary Progressive MS (SPMS)
CSF findings in Multiple Sclerosis?
Oligoclonal bands
(Ab produced by B cells - unclear if they are directly or indirectly involved)
Vitamin D supplementation is associated with what in regards to MS?
decreased lesions on MRI
Neurostimulants for chronic fatigue associated w/ MS?
Amantadine (good evidence to support use)
Methylphenidate, modafanil can also be considered
Rehab considerations for central fatigue and MS?
Focus on energy-conserving strategies, submaximal exercise is recommended
Medication approved for MS patients to increase walking speed?
Dalframpridine
Pts considered dalfampridine “responders” if they demonstrate at least 20% improvement in walking speed
Factors associated w/ good prognosis in MS?
Optic neuritis as presenting symptom, female gender, younger age at onset